The indeterminate adrenal mass in patients with cancer

Cancer Imaging

Volumn 7, Issue SPEC. ISS. A, 2007, Pages

  Sahdev, Anju ^a   Reznek, R H ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adenomas; CT; Metastases; MRI; PET

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; LIPID; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADENOMA; ADRENAL BIOPSY; ADRENAL CANCER; ADRENAL CYST; ADRENAL HEMORRHAGE; ADRENAL HYPERPLASIA; ADRENAL TUMOR; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HISTOGRAM; HUMAN; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY AND SPECIFICITY; ADRENAL DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; INCIDENTAL FINDING; NEOPLASM; PATHOLOGY;

ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35848950949     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.9017     Document Type: Review

References (49)

1. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL. Non-functioning adrenal masses: incidental discovery on computed tomography. AJR 1982; 139: 81-5.
2. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006; 29: 298-302.
3. Arnold DT, Reed JB, Burt K. Evaluation and management of the incidental adfenal mass. Proc (Bayl Univ Med Cent) 2003; 16: 7-12.
4. Libe R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005; 153: 477-87.
5. Oliver Jr TW, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in non small-cell bronchogenic carcinoma. Radiology 1984; 153: 217-8.
6. Frilling A, Tecklenborg Y, Weber F, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004; 136: 1289-96.
7. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998; 171: 201-4.
8. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179: 415-8.
9. Francis IR, Gross MD, Shapiro B, Korobkin M, Quint LE. Integrated imaging of adrenal disease. Radiology 1992; 184: 1-13 (Erratum in: Radiology 1992; 185: 286).
10. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR 2000; 175:1411-5.
11. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217: 798-802.
12. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1996; 166: 531-6.
13. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Raliology 1998; 207: 369-75.
14. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2006; 238: 578-85.
15. Dunnick NF, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR 2002; 179: 559-68.
16. Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP. Adrenal masses: CT characterization with histogram analysis method Radiology 2003; 228: 735-42.
17. Remet EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR. CT histogram analysis in pathologically proven adrenal masses. AJR 2006; 187: 191-6.
18. Jhaveri KS, Wong F, Ghai S, Haider MA. Comparison of CT hiqtogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR 2006; 187: 1303-8.
19. Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH. Adrenal masses differentiated by MR. Radiology 1986; 158: 81-4.
20. Chang A, Glazer HS, Lee JK, Ling D, Heiken JP. Adrenal gland: MR imaging. Radiology 1987; 163: 123-8.
21. Glazer GM, Woolsey EJ, Borrello J, et al. Adrenal tissue characterization using MR imaging. Radiology 1986; 158: 73-9.
22. Inan N, Arslan A, Akansel G, Anik Y, Balci NC, Demirci A. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal 4denomas and malignant adrenal masses. Eur J Radiol 2007(Apr 25; Epub ahead of print).
23. Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and GdDTPA-enhanced dynamic studies. Radiology 1989; 171: 675-80.
24. Semelka RC, Shoenut JP, Lawrence PH, et al. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging 1993; 3: 337-43.
25. Chung JJ, Semelka RC, Martin DR. Adrenal adeitomas: characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging 2001; 13: 242-8.
26. Ichikawa T, Ohtomo K, Uchiyama G, et al. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images. Radiology 1994; 193: 247-50.
27. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995; 165: 91-5.
28. Dunnick NR, Korohkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR 1996; 167: 861-7.
29. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shik fast low-angle shot MR imaging. Radiology 1993; 186: 705-9.
30. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200: 743-7.
31. Al-Hawary MM, Francis IF, Korobkin M. Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 2005; 19: 277-92.
32. Elias D, et al. Comparison of chemical shift imaging and non-contrast CT in the diagnosis of adrenal adenomas (abstract). Radiology 2001; 217: 416.
33. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still haft a role? Radiology 2004; 231: 711-6.
34. Savci G, Yazici Z, Sahin N, Akgoz S, Tuncel E. Value of Chemical shift subtraction MRI in characterization of adrenal masses. AJR 2006; 86: 130-5.
35. Lowe, VJ, Naunheim KS. Current role of positron emission tomography in thoracic oncology. Thorax 108; 53: 703-12.
36. Erasmus JJ, McAdams HP, Patz Jr EF. Non-small cell lung cancer: FDG-PET. imaging. J Thorac Imaging 1999; 14; 247-56.
37. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42: 1795-9.
38. Caoili EM, Korobkin M, Brown RK, Mackie G, Shulkin BL. Diffentiating adrenal ademoas from nonadenomas using (18)F-FDG PET/CT quantitative and qualitative evaluation. Acad Radiol 2007; 44: 468-75.
39. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: characterization with fused PET/CT. image in patients with proved or supected malignancy-initial experience. Radiology 2006; 238: 970-7.
40. Chong S, Lee KS, Kim HY, et al. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 2006; 26: 1811-24.
41. Maurea S, Mainolfi C, Bazzicalupo L, et al. Imaging of adrenal tumors using FDG PET. comparison of benign and malignant lesions. AJR 1999; 173: 25-9.
42. 11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 2006; 91: 1410-4.
43. 18F-PDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006; 47: 32-7.
44. Harisinghani MG, Maher MM, Hahn PF, et al. Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol 2002; 57: 898-901.
45. Welch TJ, Sheedy 2nd PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year exprrience. Radiology 1994; 193: 341-4.
46. Mody MK, Kazerooni EA, Korobkin M. Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 1995; 19: 434-9.
47. Vincent JM, Morrison ID, Armstrong P, Reznek RH. Computed tomography of diffuse, non-metastatic enlargement of the adrenal glands in patients with malignant disease. Clin Radiol 1994; 49: 456-60.
48. Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R. Adrenal enlargement and fuilure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 1999; 80: 1815-9.
49. Benitah N, Yeh, BM, Qayyum A, Williams G, Breiman RS, Coakley FV. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer. Radiology 2005; 235: 517-22.